(Q37323814)

19 August 2017

Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer (English)

1 reference

19 August 2017

1 reference

1 reference

Kwang Hyun Paik

1

1 reference

19 August 2017

Yeon Hee Park

2

1 reference

19 August 2017

Baek-Yeol Ryoo

3

1 reference

19 August 2017

Sung Hyun Yang

4

1 reference

19 August 2017

Jae Cheol Lee

5

1 reference

19 August 2017

Cheol Hyun Kim

6

1 reference

19 August 2017

Seung Seog Ki

7

1 reference

19 August 2017

Jung Min Kim

8

1 reference

19 August 2017

Myung Joon Park

9

1 reference

19 August 2017

Heui June Ahn

10

1 reference

19 August 2017

Won Choi

11

1 reference

19 August 2017

Jin Haeng Chung

12

1 reference

19 August 2017

1 February 2006

1 reference

Journal of Korean Medical Science

19 August 2017

1 reference

19 August 2017

21

1 reference

19 August 2017

1

1 reference

19 August 2017

35-39

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

19 August 2017

start time

1 January 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

DNA ploidy and proliferative activity in bcl-2 expressed non-small cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

P53, cell cycle control and apoptosis: Implications for cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Chemical and physical carcinogenesis: advances and perspectives for the 1990s

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Bcl-2 initiates a new category of oncogenes: regulators of cell death

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

bcl-2 protein in non-small-cell lung carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

The relationship of p53 immunostaining to survival in carcinoma of the lung

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Accumulation of p53 protein correlates with a poor prognosis in human lung cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

26 June 2018

Bcl-2 family proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733975

Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells

2 September 2018

1 reference

12 December 2020

Ki-67 immunostaining and survival in operable lung cancer

1 reference

12 December 2020

bcl-2 and prognosis in non-small-cell lung carcinoma

1 reference

12 December 2020

What does BCL-2 mean in solid tumours--friend or foe?

1 reference

12 December 2020

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor

1 reference

12 December 2020

Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours

1 reference

12 December 2020

Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer

1 reference

12 December 2020

Proliferating cell nuclear antigen and Ki-67 antigen expression in human haematopoietic cells during growth stimulation and differentiation

1 reference

12 December 2020

The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction

1 reference

12 December 2020

Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer

1 reference

12 December 2020

Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer

1 reference

12 December 2020

Survival in small cell lung carcinoma is independent of Bcl-2 expression

1 reference

12 December 2020

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

1 reference

12 December 2020

Biological prognostic factors for early stage completely resected non-small cell lung cancer

1 reference

12 December 2020

Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome

1 reference

12 December 2020

Correlation of p53 oncoprotein expression with chemotherapy response in small cell lung carcinomas

1 reference

12 December 2020

Identity of the proliferating cell nuclear antigen and cyclin

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Prognostic significance of Ki67 labelling in resected non small cell lung cancer

1 reference

12 December 2020

10.3346/JKMS.2006.21.1.35

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

16479062

1 reference